All treatments
Treatment
Lucentis 10 mg/ml solution for injection clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia
This study is testing a new medicine, Faricimab, against an existing treatment, Lucentis, for an eye condition called choroidal neovascularization caused by severe short-sightedness. Researchers want to see if Faricimab can improve vision and is safe to use.
For: Choroidal neovascularization secondary to pathologic myopiaPoland · France · Germany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-Blind, Parallel Group, Multicenter Study to Compare Efficacy, Safety, Pharmacokinetics, and Immunogenicity of BP05 Versus EU-Approved Lucentis® in Patients with Wet (Neovascular) Age-Related Macular Degeneration
This study is testing a new version of an eye medicine, ranibizumab (like Lucentis), for wet age-related macular degeneration. Researchers want to see if the new version works as well and is as safe as the original to help people see better.
For: wet macula degenerationSlovakia · Latvia